Abstract
AbstractA chimeric peptide derived from Lactoferricin B (LfcinB) and Buforin II (BFII) was designed. It specifically contains the reported antimicrobial minimal motif sequences LfcinB (20–25): RRWQWR and BFII (32–35): RLLR. The chimeric peptide was synthesized by intramolecular cyclization with a triazole bridge. The Chimera 3 exhibited higher antimicrobial activity against E. coli ATCC 25922 (MIC 93 μM) and S. aureus ATCC 25923 (93 μM) than the original sequences. Furthermore, it did not exhibit a significant hemolytic effect.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
